Your browser doesn't support javascript.
loading
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma.
Frigault, Matthew J; Bishop, Michael R; Rosenblatt, Jacalyn; O'Donnell, Elizabeth K; Raje, Noopur; Cook, Daniella; Yee, Andrew J; Logan, Emma; Avigan, David E; Jakubowiak, Andrzej; Shaw, Kit; Daley, Heather; Nikiforow, Sarah; Griffin, Faith; Cornwell, Christine; Shen, Angela; Heery, Christopher; Maus, Marcela V.
Afiliación
  • Frigault MJ; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Bishop MR; Harvard Medical School, Boston, MA.
  • Rosenblatt J; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL.
  • O'Donnell EK; Beth Israel Deaconess Medical Center, Boston, MA.
  • Raje N; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Cook D; Harvard Medical School, Boston, MA.
  • Yee AJ; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Logan E; Harvard Medical School, Boston, MA.
  • Avigan DE; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Jakubowiak A; Harvard Medical School, Boston, MA.
  • Shaw K; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Daley H; Harvard Medical School, Boston, MA.
  • Nikiforow S; Beth Israel Deaconess Medical Center, Boston, MA.
  • Griffin F; Beth Israel Deaconess Medical Center, Boston, MA.
  • Cornwell C; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL.
  • Shen A; Dana Farber Cancer Institute, Cell Manipulation Core Facility, Brookline, MA.
  • Heery C; Dana Farber Cancer Institute, Cell Manipulation Core Facility, Brookline, MA.
  • Maus MV; Dana Farber Cancer Institute, Cell Manipulation Core Facility, Brookline, MA.
Blood Adv ; 7(5): 768-777, 2023 03 14.
Article en En | MEDLINE | ID: mdl-35468618
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes de Neurotoxicidad / Receptores Quiméricos de Antígenos / Mieloma Múltiple Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Marruecos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes de Neurotoxicidad / Receptores Quiméricos de Antígenos / Mieloma Múltiple Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Marruecos Pais de publicación: Estados Unidos